Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

including a smart insulin pen that tracks doses and a body worn monitor that makes real-time glucose readings for people who make multiple daily injections. Diabetes management is challenging ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market ...

Advancements in insulin pens help the growth of the market. Smart insulin pens are digital; through the internet, pens automatically share information about the time and amount of insulin received ...

In this study, significantly more patients in the insulin pen group prepared and self-injected at least one dose of insulin compared with the vial and syringe group. Patients with newly diagnosed ...

Smart Insulin, also known as Glucose Responsive Insulin ... Advanced diabetic therapy in the form of insulin patches, insulin pens, continuous glucose monitoring systems (CGMS), and artificial ...